Home Cart 0 Sign in  
X

[ CAS No. 33166-77-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 33166-77-7
Chemical Structure| 33166-77-7
Chemical Structure| 33166-77-7
Structure of 33166-77-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 33166-77-7 ]

Related Doc. of [ 33166-77-7 ]

Alternatived Products of [ 33166-77-7 ]

Product Details of [ 33166-77-7 ]

CAS No. :33166-77-7 MDL No. :MFCD03424809
Formula : C11H11FO3 Boiling Point : -
Linear Structure Formula :- InChI Key :MLABEWHVTXMKHP-UHFFFAOYSA-N
M.W : 210.20 Pubchem ID :2063904
Synonyms :

Calculated chemistry of [ 33166-77-7 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.27
Num. rotatable bonds : 5
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 52.3
TPSA : 43.37 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.18 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.04
Log Po/w (XLOGP3) : 1.97
Log Po/w (WLOGP) : 2.38
Log Po/w (MLOGP) : 2.02
Log Po/w (SILICOS-IT) : 2.74
Consensus Log Po/w : 2.23

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.35
Solubility : 0.938 mg/ml ; 0.00446 mol/l
Class : Soluble
Log S (Ali) : -2.51
Solubility : 0.655 mg/ml ; 0.00312 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.52
Solubility : 0.0638 mg/ml ; 0.000303 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.71

Safety of [ 33166-77-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 33166-77-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 33166-77-7 ]
  • Downstream synthetic route of [ 33166-77-7 ]

[ 33166-77-7 ] Synthesis Path-Upstream   1~7

  • 1
  • [ 455-36-7 ]
  • [ 105-58-8 ]
  • [ 33166-77-7 ]
YieldReaction ConditionsOperation in experiment
69% With sodium hydride In toluene; mineral oil General procedure: The substrate b-ketoesters 10 a–n were either purchased or synthesized following published procedures. Some benzoylacetates were commercially available. Ethyl 3-oxo-3-phenyl propanoate (10a) was purchased. The reaction of benzoylacetates 10 b–n was prepared as described in previous reports. 25–27 A solution of a substituted acetophenone 8 a–n (0.05 mol) dissolved in toluene (50 mL) was added dropwise to a solution containing diethyl carbonate (9) (0.10 mol) and sodium hydride (0.15 mol 60percent dispersion in mineral oil). The mixture was stirred at room temperature, and then refluxed for 30 min. The mixture was poured into ice water,acidified with glacial acetic acid, and extracted with EtOAc (3x100 mL). The EtOAc extract was then dried over anhydrous MgSO4. After removal of the solvent in vacuo, the crude products were purified by silica gel column chromatography eluting with dichloromethane to afford benzoylacetates 10 b–n. All synthetic compounds were in agreement with 1H NMR, 13C NMR, IR and mass spectroscopic data.
58% With sodium hydride In toluene; mineral oil for 0.333333 h; Reflux General procedure: General procedure for the synthesis of ethyl 3-substituted-3-oxopropanoate (1 1-20) To a stirring suspension of NaH and CO(OEt)2 (10) in toluene was added dropwise a solution of substituted acetophenone (1-9) in toluene under reflux. The mixture was allowed to reflux and was stirred for 20 min after the addition was complete. When cooled to room temperature, the mixture was acidified with glacial HOAc. After ice-cold water was added, the mixture was extracted with toluene. The extract was then dried over anhydrous MgS04. After the toluene was evaporated in vacuo to give the corresponding substituted ethyl 3-phenyl-3-oxopropanoate
Reference: [1] Bioorganic and Medicinal Chemistry, 2013, vol. 21, # 17, p. 5064 - 5075
[2] Patent: WO2014/179401, 2014, A1, . Location in patent: Page/Page column 9; 14; 15
[3] Journal of Medicinal Chemistry, 1997, vol. 40, # 19, p. 3049 - 3056
[4] European Journal of Organic Chemistry, 2015, vol. 2015, # 17, p. 3656 - 3660
[5] Chemical Communications, 2017, vol. 53, # 58, p. 8136 - 8139
[6] Organic and Biomolecular Chemistry, 2018, vol. 16, # 25, p. 4683 - 4687
  • 2
  • [ 6148-64-7 ]
  • [ 776-71-6 ]
  • [ 33166-77-7 ]
Reference: [1] Patent: US2008/188521, 2008, A1, . Location in patent: Page/Page column 19-20
[2] Organic Process Research and Development, 2012, vol. 16, # 2, p. 214 - 219
  • 3
  • [ 455-38-9 ]
  • [ 6148-64-7 ]
  • [ 33166-77-7 ]
Reference: [1] RSC Advances, 2018, vol. 8, # 27, p. 15009 - 15020
  • 4
  • [ 451-02-5 ]
  • [ 141-78-6 ]
  • [ 33166-77-7 ]
Reference: [1] Organic Process Research and Development, 2010, vol. 14, # 3, p. 592 - 599
  • 5
  • [ 64-17-5 ]
  • [ 223679-80-9 ]
  • [ 33166-77-7 ]
Reference: [1] Patent: US2012/277224, 2012, A1, . Location in patent: Page/Page column 28
  • 6
  • [ 455-38-9 ]
  • [ 33166-77-7 ]
Reference: [1] Organic Process Research and Development, 2012, vol. 16, # 2, p. 214 - 219
[2] Patent: US2012/277224, 2012, A1,
  • 7
  • [ 64-17-5 ]
  • [ 33166-77-7 ]
Reference: [1] Bioorganic and Medicinal Chemistry, 2008, vol. 16, # 20, p. 9349 - 9358
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 33166-77-7 ]

Fluorinated Building Blocks

Chemical Structure| 1999-00-4

[ 1999-00-4 ]

Ethyl 3-(4-fluorophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 887267-53-0

[ 887267-53-0 ]

Ethyl 3-(2,5-difluorophenyl)-3-oxopropanoate

Similarity: 0.96

Chemical Structure| 1479-24-9

[ 1479-24-9 ]

Ethyl 3-(2-fluorophenyl)-3-oxo-propionate

Similarity: 0.96

Chemical Structure| 31686-94-9

[ 31686-94-9 ]

Ethyl 4-(4-fluorophenyl)-2,4-dioxobutanoate

Similarity: 0.87

Chemical Structure| 98349-24-7

[ 98349-24-7 ]

Ethyl 2,4,5-trifluorobenzoylacetate

Similarity: 0.85

Aryls

Chemical Structure| 1999-00-4

[ 1999-00-4 ]

Ethyl 3-(4-fluorophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 887267-53-0

[ 887267-53-0 ]

Ethyl 3-(2,5-difluorophenyl)-3-oxopropanoate

Similarity: 0.96

Chemical Structure| 1479-24-9

[ 1479-24-9 ]

Ethyl 3-(2-fluorophenyl)-3-oxo-propionate

Similarity: 0.96

Chemical Structure| 31686-94-9

[ 31686-94-9 ]

Ethyl 4-(4-fluorophenyl)-2,4-dioxobutanoate

Similarity: 0.87

Chemical Structure| 98349-24-7

[ 98349-24-7 ]

Ethyl 2,4,5-trifluorobenzoylacetate

Similarity: 0.85

Esters

Chemical Structure| 1999-00-4

[ 1999-00-4 ]

Ethyl 3-(4-fluorophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 887267-53-0

[ 887267-53-0 ]

Ethyl 3-(2,5-difluorophenyl)-3-oxopropanoate

Similarity: 0.96

Chemical Structure| 1479-24-9

[ 1479-24-9 ]

Ethyl 3-(2-fluorophenyl)-3-oxo-propionate

Similarity: 0.96

Chemical Structure| 31686-94-9

[ 31686-94-9 ]

Ethyl 4-(4-fluorophenyl)-2,4-dioxobutanoate

Similarity: 0.87

Chemical Structure| 98349-24-7

[ 98349-24-7 ]

Ethyl 2,4,5-trifluorobenzoylacetate

Similarity: 0.85

Ketones

Chemical Structure| 1999-00-4

[ 1999-00-4 ]

Ethyl 3-(4-fluorophenyl)-3-oxopropanoate

Similarity: 0.98

Chemical Structure| 887267-53-0

[ 887267-53-0 ]

Ethyl 3-(2,5-difluorophenyl)-3-oxopropanoate

Similarity: 0.96

Chemical Structure| 1479-24-9

[ 1479-24-9 ]

Ethyl 3-(2-fluorophenyl)-3-oxo-propionate

Similarity: 0.96

Chemical Structure| 31686-94-9

[ 31686-94-9 ]

Ethyl 4-(4-fluorophenyl)-2,4-dioxobutanoate

Similarity: 0.87

Chemical Structure| 98349-24-7

[ 98349-24-7 ]

Ethyl 2,4,5-trifluorobenzoylacetate

Similarity: 0.85